Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma
Ryusei Matsuyama, Rintaro Mori, Yohei Ota, Yuki Homma, Yasuhiro Yabusita, Seigo Hiratani, Takashi Murakami, Yu Sawada, Kentaro Miyake, Yasuhiro Shimizu, Takafumi Kumamoto, Itaru Endo
Topics & Concepts
MedicineGemcitabineSurgical oncologyNeoadjuvant therapyNeutropeniaSurvival rateChemotherapySurgeryInternal medicineClinical endpointOncologyCancerRandomized controlled trialBreast cancerCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersPancreatic and Hepatic Oncology Research